+ 1 888 391 5441
Sort By
Title Published Price Buy Now
Investigation Report on China Salmon Calcitonin Market, 2010-2019
By China Research and Intelligence
China has become the country with the largest number of osteoporosis patients. A nationwide large-scale epidemiological survey has also shown that the incidence of osteoporosis in China has exceeded 12% and that this figure among elders is over 50...
Jun 2015 $ 2000
Investigation Report on China Moxifloxacin Market, 2010-2019
By China Research and Intelligence
As the fourth generation of quinolones drugs, moxifloxacin (moxifloxacin hodrochloride) was first introduced to the market by The Bayer Group in Sep. 1999. It is utilized in the treatment of adult patients (aged 18 and above) diagnosed with upper ...
Jun 2015 $ 2000
Investigation Report on China Levothyroxine Market, 2010-2019
By China Research and Intelligence
Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones mainly promote the growth and development of bones, brain and reproductive organs, even the growth hormone (GH) o...
Jun 2015 $ 2000
Investigation Report on China Menotropins Market, 2010-2019
By China Research and Intelligence
According to the statistics, at present there are about 100 million women in the high-fertility period (aged 20-29) in China, over 12% of whom suffer from infertility. About 30% of female diagnosed with infertility suffer from ovulation inhibition...
Jun 2015 $ 2000
Investigation Report on China Ossotide Market, 2010-2019
By China Research and Intelligence
According to statistics, the incidence of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of degraded joint function, is also common to see. With the ageing pop...
Jun 2015 $ 2000
Investigation Report on China Rosuvastatin Market, 2010-2019
By China Research and Intelligence
First developed by Shionogi Inc. under the code name of S-4522 at the end of 1980s, rosuvastatin (rosuvastatin calcium) along with its development, marketing and sales rights, was transferred to AstraZeneca in Jun. 1998 under the code name of ZD-4...
Jun 2015 $ 2000
Investigation Report on China Glucosamine Market, 2010-2019
By China Research and Intelligence
Osteoarthritis (OA) is a kind of chronic degenerative disease, and it is also the commonest arthritis in the clinic. The lesion is a slow yet progressing process. Major symptoms include wearing away and damage of articular cartilage, whereas clini...
Jun 2015 $ 2000
Investigation Report on China Liraglutide Market, 2011-2019
By China Research and Intelligence
Description As economy develops and living standards improve, Chinese people's dietary pattern changes, resulting in excess heat. Meanwhile, the drop in physical activities leads to the increased obesity rate. Other factor...
Jun 2015 $ 2000
Investigation Report on China Capecitabine Market, 2010-2019
By China Research and Intelligence
Description Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in 2 years. In ...
Jun 2015 $ 2000
Investigation Report on China Tacrolimus Market, 2010-2019
By China Research and Intelligence
Description Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus...
Jun 2015 $ 2000
Investigation Report on China Recombinant Factor VIII Market, 2010-2019
By China Research and Intelligence
Description Hemophilia is a hereditary bleeding disorder caused by a lack of clotting factor VIII or IX, though not rare, which affects mostly males. Hemophilia A (clotting factor VIII deficiency) is the most common form o...
Jun 2015 $ 2000
Investigation Report on China Atorvastatin Market, 2010-2019
By China Research and Intelligence
Description With the change of life styles brought about by the economic development and the rising incomes, the number of hyperlipidemia patients in China keeps growing, being estimated to reach 160-200 million in the nea...
Jun 2015 $ 2000
Investigation Report on China Insulin Lispro Market, 2010-2019
By China Research and Intelligence
Description According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382 million i...
Jun 2015 $ 2000
Investigation Report on China Celecoxib Market, 2010-2019
By China Research and Intelligence
Description Currently, there are over 30 million people around the world using nonsteroidal antiinflammatory drugs (NSAIDs) as antiinflammatory painrelief drugs. However, many drugs under the category of NSAIDs cause gastr...
Jun 2015 $ 2000
Investigation Report on China Edaravone Market, 2010-2019
By China Research and Intelligence
Description Cerebrovascular disease is one of the three principal diseases that can cause people to death. Acute cerebral infarction which occupies 70% of cerebrovascular disease has a disability rate of 50%70% and a recur...
Jun 2015 $ 2000
Investigation Report on China Budesonide Market, 2010-2019
By China Research and Intelligence
Description With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the inci...
Jun 2015 $ 2000
Investigation Report on China Octreotide Market, 2010-2019
By China Research and Intelligence
Description Octreotide, an octapeptide that mimics natural somatostatin, has been widely used in clinic for the treatment of upper gastrointestinal variceal hemorrhage and stomach ulcer bleeding, acute pancreatitis, endocr...
Jun 2015 $ 2000
Investigation Report on China Desloratadine Market, 2010-2019
By China Research and Intelligence
Description Histamine, a substance which can lead to inflammation and anaphylaxis, is one of the important chemical mediators of immediate anaphylaxis (the most common type I allergy in clinic). The incidence of allergy ha...
Jun 2015 $ 2000
Investigation Report on China Methylprednisolone Market, 2010-2019
By China Research and Intelligence
Description Ever since the 1990s, steroid has entered its golden age with over 120 varieties being made for application and sales value in the global market increasing by 10%-15% each year. During the process of product re...
Jun 2015 $ 2000
Investigation Report on China Doxofylline Market, 2010-2019
By China Research and Intelligence
Description With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the inci...
Jun 2015 $ 2000
Investigation Report on China Ezetimibe Market, 2010-2019
By China Research and Intelligence
Description With the sustained economic development and the improvements in diet, Chinese people's blood fat level rises too. Many local epidemiological studies on blood fat have proved that a conservative estimate of the ...
Jun 2015 $ 2000
China Pharmaceutical Glass Packaging Industry Report, 2014-2017
By Research In China
In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industry and driven growth in the demand from pharmaceutical packaging industry. In 2014, the Chinese pharmaceutical packaging market reached ...
Jun 2015 $ 1550
Investigation Report on China Nicergoline Market, 2010-2019
By China Research and Intelligence
Nicergoline is a kind of ergot alkaloid, which can dilatate the blood vessel of brain and improve the blood supply of brain. It can block ?receptor and accelerate metabolism as well as reduce the resistance of the blood vessel of brain and increas...
May 2015 $ 2000
Investigation Report on China Esomeprazole Market, 2010-2019
By China Research and Intelligence
Digestive system disease is one of frequently occurring diseases. According to statistics of WHO, there are at least 250 million digestive tract patients, mainly suffering from canker. Inhibition of gastric acid secretion is the key treatm...
May 2015 $ 2000
Investigation Report on China Rituximab Market, 2010-2019
By China Research and Intelligence
Rituximab (trade name is Rituxan by Roche) was a humanmouse chimeric antiCD20 monoclonal antibody approved by FDA to treat tumor in 1997. The treatment range of Rituximab extends from Bcell malignant tumors to rheumatoid arthritis, systemic lupus ...
May 2015 $ 2000
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy